PHILADELPHIA (August 21, 2019) – John Karanicolas, PhD, was recently promoted to the rank of Professor at Fox Chase Cancer Center. Reviewers highlighted the ...
John Karanicolas
Affiliation: Temple University
Research interests: Designing small-molecule modulators of protein activity using computational and biochemical approaches
John Karanicolas, Molecular Therapeutics Program, Fox Chase Cancer Center. Verified email at fccc.edu - Homepage Designing small-molecule modulators of protein ...
Head of Computational Drug Discovery at AbbVie · Experience: AbbVie · Location: North Chicago · 500+ connections on LinkedIn. View John Karanicolas' profile ...
Advancing scientific knowledge to benefit human health. Head of computational drug discovery at AbbVie.
John KARANICOLAS, Professor | Cited by 8401 | of Fox Chase Cancer Center, Philadelphia | Read 140 publications | Contact John KARANICOLAS.
Feb 24, 2022 · PHILADELPHIA (February 24, 2022)—John Karanicolas, PhD, co-leader of the Molecular Therapeutics research program at Fox Chase Cancer Center, ...
Apr 17, 2019 · Adjunct Associate Professor of Biochemistry and Biophysics. Department: Biochemistry and Biophysics. Contact information: Molecular Therapeutics Group.
John KARANICOLAS, Professor | Cited by 8418 | of Fox Chase Cancer Center, Philadelphia | Read 140 publications | Contact John KARANICOLAS.